Article
Erythropoietin as a Potential Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
2021-09-24
Abstract excerpt
<title>Abstract</title> <p><bold><italic>Background.</italic></bold> Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis. Immune checkpoint genes are considered novel tumor immunotherapy targets for many cancer types. Erythropoietin (EPO) is a protein secreted mainly in the liver and kidneys; in several cancer types, EPO expression stimulates tumor growth and corelates with patient survival. T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1b66b3b8-8a91-5232-a285-c27c576e74f4
- DOI
- 10.21203/rs.3.rs-910252/v1
